ArticleThe Journal of steroid biochemistry and molecular biology2016

Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.

Craig L Doig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.